Brief: Epirus Biopharmaceuticals Q4 loss per share $0.63

Epirus Biopharmaceuticals

15/03/2016 10:00

March 15 (Reuters) - EPIRUS Biopharmaceuticals Inc  EPRS.O : 
 * Reports fourth quarter and fiscal year 2015 financial results and provides 
   business update 
 * Says company is in the process of evaluating various financing alternatives 
   for operations 
 * Says net loss was $15.4 million for the fourth quarter of 2015, compared to 
   $10.4 million 
 * Qtrly loss per share $0.63 
 
 * Source text for Eikon  urn:newsml:reuters.com:*:nGNXMOZCBa 
 
 * Further company coverage  EPRS.O  
 
 ((Bengaluru Newsroom; +1 646 223 8780))